Rhabdoviruses are a family of enveloped RNA viruses that can infect various hosts, including animals, plants, and insects. One well-known member of this family is the rabies virus, which causes the severe and often fatal disease known as rabies. Rhabdoviruses have a bullet-shaped morphology and a single-stranded, negative-sense RNA genome. They enter host cells by binding to specific receptors and are known for their ability to cause a wide range of diseases in different species. The rabies virus, transmitted through the saliva of infected animals, primarily affects mammals, including humans. Once symptoms appear, rabies is almost universally fatal if not treated promptly. Research on rhabdoviruses extends beyond their medical significance, as some members of this family also serve as valuable tools in molecular biology and gene expression studies. The study of rhabdoviruses continues to contribute to our understanding of viral pathogenesis, vaccine development, and antiviral strategies.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States